γ-MSH peptides in the pituitary: Effects, target cells, and receptors

Annals of the New York Academy of Sciences

Volumn 994, Issue , 2003, Pages 123-132

  Denef, C ^a   Lu, J ^a   Swinnen, E ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Calcium imaging; Melanocortin receptors; MTII; Pituitary; SHU9119; Single cell RT PCR; 2 MSH; 3 MSH

Indexed keywords

ALANINE; CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; GAMMA 2 INTERMEDIN; GAMMA 2 INTERMEDIN DERIVATIVE; GAMMA 3 INTERMEDIN; GAMMA INTERMEDIN; GAMMA INTERMEDIN DERIVATIVE; GAMMA INTERMEDIN RECEPTOR; GROWTH HORMONE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HORMONE RECEPTOR AFFECTING AGENT; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 3 RECEPTOR BLOCKING AGENT; MELANOCORTIN 3 RECEPTOR STIMULATING AGENT; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 4 RECEPTOR BLOCKING AGENT; MELANOCORTIN 4 RECEPTOR STIMULATING AGENT; MELANOCORTIN 5 RECEPTOR STIMULATING AGENT; MELANOCORTIN RECEPTOR BLOCKING AGENT; MELANOCORTIN RECEPTOR STIMULATING AGENT; MESSENGER RNA; METHIONINE; MTII; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PEPTIDE DERIVATIVE; PROLACTIN; UNCLASSIFIED DRUG;

AGONIST; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CALCIUM CELL LEVEL; CALCIUM IMAGING; CELL STRAIN GH3; CELL SUBPOPULATION; CONFERENCE PAPER; ENZYME INHIBITION; GENE EXPRESSION; HORMONE ACTION; HUMAN; HYPOPHYSIS; HYPOPHYSIS CELL; IMAGING; NEUROSECRETORY CELL; NONHUMAN; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SINGLE CELL REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL;

EID: 0038496906     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03171.x     Document Type: Conference Paper

References (51)

1. NAKANISHI, S., A. INOUE, T. KITA, et al. 1979. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature 278: 423-427.
2. SHIBASAKI, T., N. LING & R. GUILLEMIN. 1980. Pituitary immunoreactive gamma-melanotropins are glycosylated oligopeptides. Nature 285: 416-417.
3. BLOOM, F.E., E.L. BATTENBERG, T. SHIBASAKI, et al. 1980. Localization of gamma-melanocyte stimulating hormone (gamma MSH) immunoreactivity in rat brain and pituitary. Regul. Pept. 1: 205-222.
4. PELLETIER, G., R. LECLERC, S. BENJANNET, et al. 1981. Immunohistochemical localization of gamma-melanocyte-stimulating hormone in the rat pituitary gland. Regul. Pept. 2: 81-89.
5. SHIBASAKI, T., N. LING & R. GUILLEMIN. 1980. A radioimmunoassay for gamma 1-melanotropin and evidence that the smallest pituitary gamma-melanotropin is amidated at the COOH-terminus. Biochem. Biophys. Res. Commun. 96: 1393-1399.
6. PEDERSEN, R.C., N. LING & A.C. BROWNIE. 1982. Immunoreactive gamma-melanotropin in rat pituitary and plasma: a partial characterization. Endocrinology 110: 825-834.
7. BJARTELL, A., R. EKMAN & F. SUNDLER. 1987. gamma 2-MSH-like immunoreactivity in porcine pituitary and adrenal medulla. An immunochemical and immunocytochemical study. Regul. Pept. 19: 291-306.
8. FENGER, M. 1988. Pro-opiomelanocortin-derived peptides in the pig pituitary: alpha- and gamma 1-melanocyte-stimulating hormones and their glycine-extended forms. Regul. Pept. 20: 345-357.
9. OKI, S., K. NAKAO, I. TANAKA, et al. 1982. Characterization of gamma-melanotropin-like immunoreactivity and its secretion in an adrenocorticotropin-producing mouse pituitary tumor cell line. Endocrinology 111: 418-424.
10. VAN STRIEN, F.J., B. DEVREESE, J. VAN BEEUMEN, et al. 1995. Biosynthesis and processing of the N-terminal part of proopiomelanocortin in Xenopus laevis: characterization of gamma-MSH peptides. J. Neuroendocrinol. 7: 807-815.
11. SEGER, M.A. & H.P. BENNETT. 1986. Structure and bioactivity of the amino-terminal fragment of pro-opiomelanocortin. J. Steroid Biochem. 25: 703-710.
12. FARESE, R.V., N.C. LING, M.A. SABIR, et al. 1983. Comparison of effects of adrenocorticotropin and Lys-gamma 3-melanocyte-stimulating hormone on steroidogenesis, adenosine 3′, 5′-monophosphate production, and phospholipid metabolism in rat adrenal fasciculata-reticularis cells in vitro. Endocrinology 112: 129-132.
13. PEDERSEN, R.C., A.C. BROWNIE & N. LING. 1980. Pro-adrenocorticotropin/endorphin-derived peptides: coordinate action on adrenal steroidogenesis. Science 208: 1044-1046.
14. GRUBER, K.A. & M.F. CALLAHAN. 1989. ACTH(4-10) through gamma-MSH: evidence for a new class of central autonomic nervous system-regulating peptides. Am. J. Physiol. 257: R681-R694.
15. KLUSA, V., S. SVIRSKIS, B. OPMANE, et al. 1999. Behavioural responses of gamma-MSH peptides administered into the rat ventral tegmental area. Acta Physiol. Scand. 167: 99-104.
16. CRAGNOLINI, A., T. SCIMONELLI, M.E. CELLS, et al. 2000. The role of melanocortin receptors in sexual behavior in female rats. Neuropeptides 34: 211-215.
17. LOWRY, P.J., L. SILAS, C. MCLEAN, et al. 1983. Pro-gamma-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature 306: 70-73.
18. ESTIVARIZ, F.E., M. CARINO, P.J. LOWRY, et al. 1988. Further evidence that N-terminal pro-opiomelanocortin peptides are involved in adrenal mitogenesis. J. Endocrinol. 116: 201-206.
19. ESTIVARIZ, F.E., M.I. MORANO, M. CARINO, et al. 1988. Adrenal regeneration in the rat is mediated by mitogenic N-terminal pro-opiomelanocortin peptides generated by changes in precursor processing in the anterior pituitary. J. Endocrinol. 116: 207-216.
20. DURAND, P., A.M. CATHIARD, N.G. SEIDAH, et al. 1984. Effects of proopiomelanocortin-derived peptides, methionine-enkephalin and forskolin on the maturation of ovine fetal adrenal cells in culture. Biol. Reprod. 31: 694-704.
21. LIS, M., P. HAMET, J. GUTKOWSKA, et al. 1981. Effect of N-terminal portion of pro-opiomelanocortin on aldosterone release by human adrenal adenoma in vitro. J. Clin. Endocrinol. Metab. 52: 1053-1056.
22. PEDERSEN, R.C., A.C. BROWNIE & N. LING. 1980. Pro-adrenocorticotropin/endorphin-derived peptides: coordinate action on adrenal steroidogenesis. Science 208: 1044-1046.
23. PEDERSEN, R.C. & A.C. BROWNIE. 1980. Adrenocortical response to corticotropin is potentiated by part of the amino-terminal region of pro-corticotropin/endorphin. Proc. Natl. Acad. Sci. USA 77: 2239-2243.
24. PHAM-HUU-TRUNG, M.T., A. BOGYO, N. DE SMITTER, et al. 1985. Effects of proopiomelanocortin peptides and angiotensin II on steroidogenesis in isolated aldosteronoma cells. J. Clin. Endocrinol. Metab. 61: 467-471.
25. SCHIFFRIN, E.L., M. CHRETIEN, N.G. SEIDAH, et al. 1983. Response of human aldosteronoma cells in culture to the N-terminal glycopeptide of pro-opiomelanocortin and gamma 3-MSH. Horm. Metab. Res. 15: 181-184.
26. SHARP, B. & J.R. SOWERS. 1983. Adrenocortical response to corticotropin is inhibited by gamma 3-MSH antisera in normotensive and spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 110: 357-363.
27. BICKNELL, A.B., K. LOMTHAISONG, R.J. WOODS, et al. 2001. Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth. Cell 105: 903-912.
28. XIA, Y., J.E. WIKBERG & T.L. KRUKOFF. 2001. Gamma(2)-melanocyte-stimulating hormone suppression of systemic inflammatory responses to endotoxin is associated with modulation of central autonomic and neuroendocrine activities. J. Neuroimmunol. 120: 67-77.
29. GETTING, S.J., G.H. ALLCOCK, R. FLOWER, et al. 2001. Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J. Leukoc. Biol. 69: 98-104.
30. CHHAJLANI, V. & J.E.S. WIKBERG. 1992. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309: 417-420.
31. MOUNTJOY, K.G., L.S. ROBBINS, M.T. MORTRUD, et al. 1992. The cloning of a family of genes that encode the melanocortin receptors. Science 257: 1248-1251.
32. ROSELLI-REHFUSS, L., K.G. MOUNTJOY, L.S. ROBBINS, et al. 1993. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. USA 90: 8856-8860.
33. CHHAJLANI, V., R. MUCENIECE & J.E.S. WIKBERG. 1993. Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun. 195: 866-873.
34. GANTZ, I., Y. KONDA, T. TASHIRO, et al. 1993. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268: 8246-8250.
35. GANTZ, I., H. MIWA, Y. KONDA, et al. 1993. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268: 15174-15179.
36. SCHWARTZ, J. 2000. Intercellular communication in the anterior pituitary. Endocrinol. Rev. 21: 488-513.
37. HOUBEN, H. & C. DENEF. 1994. Bioactive peptides in anterior pituitary cells. Peptides 15: 547-582.
38. TILEMANS, D., M. ANDRIES, P. PROOST, et al. 1994. In vitro evidence that an 11-kilodalton N-terminal fragment of proopiomelanocortin is a growth factor specifically stimulating the development of lactotrophs in rat pituitary during postnatal life. Endocrinology 135: 168-174.
39. VAN BAEL, A., V. VANDE VIJVER, B. DEVREESE, et al. 1996. N-terminal 10 and 12 kDa POMC fragments stimulate differentiation of lactotrophs. Peptides 17: 1219-1228.
40. TILEMANS, D., D.RAMAEKERS, M. ANDRIES, et al. 1997. Effect of POMC1-76, its C-terminal fragment γ3-MSH and anti-POMC1-76 antibodies on DNA replication in lactotrophs in aggregate cell cultures of immature rat pituitary. J. Neuroendocrinol. 9: 627-637.
41. 2+ responses in immature rat pituitary constitute a fraction of all main pituitary cell types, but mostly express multiple hormone phenotypes at the messenger ribonucleic acid level. Refractoriness to melanocortin-3 receptor blockade in the lacto-somatotroph lineage. Endocrinology 140: 4874-4885.
42. SEUNTJENS, E., A. HAUSPIE, H. VANKELECOM, et al. 2002. Ontogeny of plurihormonal cells in the anterior pituitary of the mouse, as studied by means of hormone mRNA detection in single cells. J. Neuroendocrinol. 14: 611-619.
43. HAUSPIE, A., E. SEUNTJENS, H. VANKELECOM, et al. 2003. Stimulation of combinatorial expression of prolactin and glycoprotein hormone alpha-subunit genes by GnRH and estradiol-17beta in single rat pituitary cells during aggregate cell culture. Endocrinology 144: 388-399.
44. 2+ concentration? J. Neuroendocrinol. 11: 171-179.
45. HRUBY, V.J., D. LU, S.D. SHARMA, et al. 1995. Cyclic lactam a-melanotropin analogues of Ac-Nle4-cyclo[Asp5,D-Phe7,Lys10] a-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38: 3454-3461.
46. LANGOUCHE, L., M. ROUDBARAKI, K. PALS, et al. 2001. Stimulation of intracellular free calcium in GH3 cells by gamma3-melanocyte-stimulating hormone. Involvement of a novel melanocortin receptor? Endocrinology 142: 257-266.
47. LANGOUCHE, L., K. PALS & C. DENEF. 2002. Structure-activity relationship and signal transduction of gamma-MSH peptides in GH3 cells: further evidence for a new melanocortin receptor. Peptides 23: 1077-1086.
48. NIJSEN, M.J., G.J. DE RUITER, C.M. KASBERGEN, et al. 2000. Relevance of the C-terminal Arg-Phe sequence in gamma(2)-melanocyte-stimulating hormone (gamma(2)-MSH) for inducing cardiovascular effects in conscious rats. Br. J. Pharmacol. 131: 1468-1474.
49. LI, S.J., K. VARGA, P. ARCHER, et al. 1996. Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones. J. Neurosci. 16: 5182-5188.
50. KLUSA, V., S. GERMANE, S. SVIRSKIS, et al. 2001. The gamma(2)-MSH peptide mediates a central analgesic effect via a GABA-ergic mechanism that is independent from activation of melanocortin receptors. Neuropeptides 35: 50-57.
51. LU, J., E. SWINNEN, P. PROOST, et al. 2002. Isolation and structure-bioactivity characterization of glycosylated N-POMC isoforms. J. Neuroendocrinol. 14: 869-879.